Mail & Guardian
Mail & Guardian
Global Fund to Fight Aids, Tuberculosis and MalariaIn the news
HIV PREVENTION
Video

SA and Zambia’s HIV shot dilemma: Demand versus supply

South Africa and Zambia are grappling with a significant challenge in rolling out lenacapavir, a new six-monthly HIV prevention injection. Despite high demand and promising early…

  • Ida Jooste
11 min read
Donor funding is shrinking just as science has delivered powerful new medication that could dramatically cut new HIV infections. Photo: Felipe Varanda/IAS
HIV

Aids is no longer exceptional. What happens now?

The International Aids Conference in Rio de Janeiro highlighted a stark reality: the era of Aids exceptionalism is ending amid unprecedented funding cuts. As science delivers…

  • Mia Malan
9 min read
HIV PREVENTION

#Aids2026: Bhekisisa analysed SA’s first LEN roll-out data. Here's what it found

South Africa accounts for over half of all lenacapavir (LEN) users in Africa, with health department data revealing 31,297 of the continent's roughly 60,000 users are in the…

  • Mia Malan
  • Linda Pretorius
  • Karen Harkema
11 min read